Increased LZTS1 expression is associated with a good response to paclitaxel-based chemotherapy in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased LZTS1 expression is associated with a good response to paclitaxel-based chemotherapy in breast cancer

Published:2022-06 Issue: Volume:234 Page:153915
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Li Weidong,Wang Shuling,Li Shuai,Qian Xiaolong,Gu Feng,Guo Xiaojing,Zhang Xinmin,Fu Li

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference29 articles.

1. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors;Ishii;Proc. Natl. Acad. Sci. USA,1999

2. Individualized chemotherapy guided by the expression of ERCC1, RRM1, TUBB3, TYMS and TOP2A genes versus classic chemotherapy in the treatment of breast cancer: a comparative effectiveness study;Li;Oncol. Lett.,2021

3. Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer;Iwamoto;Chin. Clin. Oncol.,2020

4. Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: results from the American College of Surgeons Oncology Group Z1031 trial (Alliance);Ellis;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2017

5. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis;Spring;Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer;Non-coding RNA Research;2025-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3